Innovative Therapies and Tools for Screenable Disorders in Newborns (R01) | Apply Online

Opportunity Summary:

The Innovative Therapies and Tools for Screenable Disorders in Newborns (R01) opportunity (Funding Opportunity Number PAR-10-230) is an NIH discretionary grant program designed to push forward research that can directly improve outcomes for conditions identified, or potentially identifiable, through newborn screening. The central aim is to support R01 research projects that deepen the basic scientific understanding of these disorders and, most importantly, enable the development of therapeutic interventions and practical tools that make early detection meaningful by linking screening to effective treatment. The FOA emphasizes both disorders already included in newborn screening panels and "high priority" genetic conditions that could become screenable in the near future if a proven therapy exists. In this context, a high priority condition is defined in a very pragmatic way: it is a disorder that would be reasonable to screen newborns for once an efficacious therapy is available, because early identification would then translate into a clear medical benefit.

The program is sponsored by multiple NIH institutes, reflecting the wide range of conditions that fall under newborn screening and pediatric early intervention. The participating institutes include the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK), the National Institute of Neurological Disorders and Stroke (NINDS), and the National Institute on Deafness and Other Communication Disorders (NIDCD). The associated CFDA program areas listed in the source information align with these missions, including child health and human development, diabetes/digestive/kidney diseases, and deafness and communication disorders. Taken together, the NIH message is that they are looking for solid, disease-relevant R01 proposals that move the field toward interventions that can be paired with screening to change the clinical course of serious early-life conditions.

This FOA uses the Research Project Grant (R01) mechanism, which typically supports larger, more mature research plans than exploratory mechanisms. The announcement also notes that it runs in parallel with two companion FOAs with the same scientific scope but different grant mechanisms: PAR-10-231 (R03) and PAR-10-232 (R21). That structure matters because it signals that NIH is trying to fund a pipeline of work across maturity levels, from smaller pilot or feasibility projects (R03), to exploratory or high-risk/high-reward projects (R21), to more comprehensive, hypothesis-driven programs of research (R01). Applicants whose ideas require a broader set of aims, longer timelines, or more extensive validation efforts would generally align with the R01 version.

In terms of funding size and the expected number of awards, the FOA intentionally does not set a single award amount or fixed project duration. Instead, NIH states that budgets and timelines are expected to vary based on the nature and scope of the proposed research. The total dollars awarded and the number of awards will ultimately depend on the mechanism used, as well as the volume, quality, duration, and costs of the applications received. Practically speaking, that means applicants are expected to propose a budget that is well-justified by the work plan rather than shaped to fit a predetermined cap described in the summary text, and the competitiveness of applications will matter heavily in determining how many projects get funded.

Eligibility is broad and includes a wide cross-section of public and private organizations. Eligible applicants listed include institutions of higher education (public/state-controlled and private), nonprofit organizations (including both 501(c)(3) and certain non-501(c)(3) nonprofits), for-profit entities (including small businesses and other for-profit organizations), and various levels of government (state, county, city/township, special district governments, and independent school districts). The FOA also explicitly includes Native American tribal governments (federally recognized) and tribal organizations, public housing authorities/Indian housing authorities, and additional categories called out in the eligibility information, such as Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, U.S. territories or possessions, and even non-U.S. (foreign) organizations and regional organizations. There is no cost sharing or matching requirement, which lowers a common barrier for applicants and keeps the focus on scientific and translational merit.

The administrative details in the source data place this FOA in a specific historical window. It was posted and created on July 19, 2010, with an original and current closing date of September 7, 2013, and an archive date of October 8, 2013. The sponsoring agency is the National Institutes of Health, and the full announcement was hosted on the NIH grants guide website at the link provided in the opportunity record. For access or technical problems related to the announcement, the contact listed is the NIH Office of Extramural Research (OER) webmaster email.

Overall, this grant opportunity is best understood as NIH support for research that bridges newborn screening and actionable care: building the science, therapies, and enabling tools that make early identification worthwhile by providing realistic pathways to treatment or intervention for infants who would otherwise face delayed diagnosis and preventable harm.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Food and Nutrition Health Income Security and Social Services

Next opportunity: Innovative Therapies and Tools for Screenable Disorders in Newborns (R03)

Previous opportunity: Pediatric Heart Network (U10) Limited Competition for the Data Coordinating Center

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 10 230

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 10 230) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 10 230", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.